Gersina Kaun-Rega

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Austrian lipid consensus : Interdisciplinary evidence-based recommendations on prevention and treatment of lipid-associated diseases from 15 medical specialist societies

Austrian lipid consensus : Interdisciplinary evidence-based recommendations on prevention and treatment of lipid-associated diseases from 15 medical specialist societies

Journal: Wiener klinische Wochenschrift

Published: April 22, 2026

Consensus statement of the Austrian Society for Rheumatology and Rehabilitation on the management of increased cardiovascular risk in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis

Consensus statement of the Austrian Society for Rheumatology and Rehabilitation on the management of increased cardiovascular risk in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis

Journal: Wiener klinische Wochenschrift

Published: January 23, 2026

Antihyperglycemic treatment of type 2 diabetes mellitus (Update 2026)

Antihyperglycemic treatment of type 2 diabetes mellitus (Update 2026)

Journal: Wiener klinische Wochenschrift

Published: January 02, 2026

Interplay of health-related quality of life and comorbidities in people with type 2 diabetes mellitus treated in primary care settings in Austria: a countrywide cross-sectional study.

Interplay of health-related quality of life and comorbidities in people with type 2 diabetes mellitus treated in primary care settings in Austria: a countrywide cross-sectional study.

Journal: BMJ open

Published: April 15, 2025

Intrahospital Prevalence of Diabetes and Prediabetes in Medical Departments in Upper Austria.

Intrahospital Prevalence of Diabetes and Prediabetes in Medical Departments in Upper Austria.

Journal: Journal of clinical medicine

Published: April 04, 2025

Metabolic risk factor targets in relation to clinical characteristics and comorbidities among individuals with type 2 diabetes treated in primary care - The countrywide cross-sectional AUSTRO-PROFIT study.

Metabolic risk factor targets in relation to clinical characteristics and comorbidities among individuals with type 2 diabetes treated in primary care - The countrywide cross-sectional AUSTRO-PROFIT study.

Journal: Diabetes, obesity & metabolism

Published: July 30, 2024

Position paper: Open-source technology in the treatment of people living with diabetes mellitus-an Austrian perspective : Technology Committee of the Austrian Diabetes Association

Position paper: Open-source technology in the treatment of people living with diabetes mellitus-an Austrian perspective : Technology Committee of the Austrian Diabetes Association

Journal: Wiener klinische Wochenschrift

Published: July 01, 2024

Lipid-Lowering Therapy after Acute Coronary Syndrome.

Lipid-Lowering Therapy after Acute Coronary Syndrome.

Journal: Journal of clinical medicine

Published: March 05, 2024

Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2023)

Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2023)

Journal: Wiener klinische Wochenschrift

Published: March 01, 2023

RtCGM Performance at Different Sensor Wear Sites During Prolonged Aerobic Exercise - Can the rtCGM Sensor be Worn Anywhere on the Body?

RtCGM Performance at Different Sensor Wear Sites During Prolonged Aerobic Exercise - Can the rtCGM Sensor be Worn Anywhere on the Body?

Journal: Journal of diabetes science and technology

Published: August 16, 2021

The plasminogen receptor Plg-RKT regulates adipose function and metabolic homeostasis.

The plasminogen receptor Plg-RKT regulates adipose function and metabolic homeostasis.

Journal: Journal of thrombosis and haemostasis : JTH

Published: March 11, 2021

The pro-inflammatory marker soluble suppression of tumorigenicity-2 (ST2) is reduced especially in diabetic morbidly obese patients undergoing bariatric surgery.

The pro-inflammatory marker soluble suppression of tumorigenicity-2 (ST2) is reduced especially in diabetic morbidly obese patients undergoing bariatric surgery.

Journal: Cardiovascular diabetology

Published: December 03, 2019

Showing 1-12 of 18

Last Updated: 09/26/2026